CHURCHILL CAPITAL CORP
10.20
07-November-24 09:30:21
15 minutes delayed
Stocks
+0.05
+0.49%
Today's range
10.20 - 10.20
ISIN
N/A
Source
NASDAQ
-
Amplitude (NASDAQ:AMPL) Price Target Raised to $12.00
08 Nov 2024 09:36:17 By Buzz FX
-
Scotiabank Issues Pessimistic Forecast for Barrick Gold (NYSE:GOLD) Stock Price
08 Nov 2024 09:36:17 By Buzz FX
-
Genpact (NYSE:G) Price Target Raised to $48.00 | MarketBeat
08 Nov 2024 09:36:17 By Buzz FX
-
Toast (NYSE:TOST) Price Target Raised to $38.00 at Robert W. Baird
08 Nov 2024 09:36:17 By Buzz FX
-
Arcellx (NASDAQ:ACLX) Given New $115.00 Price Target at Piper Sandler
08 Nov 2024 09:36:17 By Buzz FX
-
Five9 (NASDAQ:FIVN) Price Target Raised to $46.00 at Piper Sandler
08 Nov 2024 09:36:17 By Buzz FX
-
AIA Group Ltd Sells 63,225 Shares of AT&T Inc. (NYSE:T)
08 Nov 2024 09:36:17 By Buzz FX
-
Vivid Seats (NASDAQ:SEAT) Receives Neutral Rating from Piper Sandler
08 Nov 2024 09:36:17 By Buzz FX
-
Kubota (OTCMKTS:KUBTY) Issues FY 2024 Earnings Guidance
08 Nov 2024 09:36:17 By Buzz FX
-
Needham & Company LLC Lowers Rivian Automotive (NASDAQ:RIVN) Price Target to $14.00
08 Nov 2024 09:36:17 By Buzz FX
-
Sinclair, Inc. (NASDAQ:SBGI) Announces Quarterly Dividend of $0.25
08 Nov 2024 09:36:17 By Buzz FX
-
Morguard Co. (TSE:MRC) Increases Dividend to $0.20 Per Share
08 Nov 2024 09:36:17 By Buzz FX
-
Rivian Automotive (NASDAQ:RIVN) Downgraded by Bank of America to "Neutral"
08 Nov 2024 09:36:17 By Buzz FX
-
Universal Electronics (NASDAQ:UEIC) Upgraded at Rosenblatt Securities
08 Nov 2024 09:36:17 By Buzz FX
-
Sight Sciences (NASDAQ:SGHT) Earns Neutral Rating from Piper Sandler
08 Nov 2024 09:36:17 By Buzz FX
-
Flowers Foods (NYSE:FLO) Releases FY 2024 Earnings Guidance
08 Nov 2024 09:36:17 By Buzz FX
-
Synaptics (NASDAQ:SYNA) Stock Price Expected to Rise, TD Cowen Analyst Says
08 Nov 2024 09:36:17 By Buzz FX
-
Trade Desk's (TTD) Overweight Rating Reaffirmed at Piper Sandler
08 Nov 2024 09:36:17 By Buzz FX
-
BNP Paribas Downgrades Sunrun (NASDAQ:RUN) to Neutral
08 Nov 2024 09:36:17 By Buzz FX
-
Cartesian Therapeutics (NASDAQ:RNAC) Receives "Buy" Rating from Needham & Company LLC
08 Nov 2024 09:36:17 By Buzz FX